Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (14)

2024

  1. Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

    Cytotherapy, Vol. 26, Núm. 1, pp. 25-35

2023

  1. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

2022

  1. Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy

    Immunology, Vol. 165, Núm. 2, pp. 234-249

2021

  1. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

    Trials, Vol. 22, Núm. 1

  2. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

    EClinicalMedicine, Vol. 39

  3. SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy

    Frontiers in Cell and Developmental Biology, Vol. 9

2016

  1. Common genetic polymorphisms within NFκB-related genes and the risk of developing invasive aspergillosis

    Frontiers in Microbiology, Vol. 7, Núm. AUG

  2. Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: Results from the AspBIOmics Consortium

    Infection and Immunity, Vol. 84, Núm. 3, pp. 643-657

2005

  1. Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics

    Swiss Medical Weekly

2004

  1. Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

    Bone Marrow Transplantation, Vol. 34, Núm. 1, pp. 13-20

1998

  1. Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish Registry

    Bone Marrow Transplantation, Vol. 21, Núm. 2, pp. 133-140

1997

  1. Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 25, Núm. 3-4, pp. 365-372

1984

  1. Pure red cell aplasia in Kala Azar

    Acta Haematologica, Vol. 72, Núm. 3, pp. 205-207

1983

  1. SITUACION INMUNOLOGICA CELULAR EN CINCO PACIENTES HEMOFILICOS CON INHIBIDORES SOMETIDOS A TRATAMIENTO MASIVO CON CONCENTRADOS DE F.VIII

    Sangre, Vol. 28, Núm. 5, pp. 663-665